The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manickan, E.
Right arrow Articles by Rouse, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manickan, E.
Right arrow Articles by Rouse, B. T.

The Journal of Immunology, Vol 155, Issue 1 259-265, Copyright © 1995 by American Association of Immunologists


ARTICLES

Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes

E Manickan, RJ Rouse, Z Yu, WS Wire and BT Rouse
Department of Microbiology, College of Veterinary Medicine, University of Tennessee, Knoxville 37996, USA.

Plasmid DNA encoding proteins represent a convenient novel approach to vaccination. We have investigated this "genetic immunization" approach as a means to protect against herpes simplex virus (HSV) infection using a mouse zosteriform model that mimics several aspects of reactivated HSV infection of humans. After i.m. immunization with plasmid DNA-encoding glycoprotein B (gB), (pc-gB), 80% of BALB/c mice were completely protected and lesions were delayed in the remaining animals. Upon pc-gB vaccination, the animals developed both gB- and HSV- specific IgG Ab response and the isotype examination revealed a predominance of IgG2a. These mice also have low levels (1/16) of HSV- neutralizing Abs. Immune splenocytes obtained from pc-gB-immunized mice, when restimulated in vitro with HSV resulted in production of type 1 cytokines. Evidence for CD(8+)-mediated cytotoxic T lymphocyte response was equivocal. Protection could be adoptively transferred to nude mice recipients by CD4+ T cells from pc-gB-immunized mice but not by CD8+ T cells. Our results demonstrate that genetic immunization is a potent means of inducing protection against HSV and that the mechanism of immunity responsible for clearing virus from cutaneous sites is principally by CD4+ T cells. It is likely that these cells are Th1 cells because type 1 cytokines were the major cytokines detected upon in vitro Ag stimulation.


This article has been cited by other articles:


Home page
J. Virol.Home page
T. Ishikawa, H. Yamada, A. Oyamada, F. Goshima, Y. Nishiyama, and Y. Yoshikai
Protective Role of Fas-FasL Signaling in Lethal Infection with Herpes Simplex Virus Type 2 in Mice
J. Virol., November 15, 2009; 83(22): 11777 - 11783.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Kagimoto, H. Yamada, T. Ishikawa, N. Maeda, F. Goshima, Y. Nishiyama, M. Furue, and Y. Yoshikai
A regulatory role of interleukin 15 in wound healing and mucosal infection in mice
J. Leukoc. Biol., January 1, 2008; 83(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. C. Reading, P. G. Whitney, D. P. Barr, M. Wojtasiak, J. D. Mintern, J. Waithman, and A. G. Brooks
IL-18, but not IL-12, Regulates NK Cell Activity following Intranasal Herpes Simplex Virus Type 1 Infection
J. Immunol., September 1, 2007; 179(5): 3214 - 3221.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Wang, S. A. Gujar, L. Cova, and T. I. Michalak
Bicistronic Woodchuck Hepatitis Virus Core and Gamma Interferon DNA Vaccine Can Protect from Hepatitis but Does Not Elicit Sterilizing Antiviral Immunity
J. Virol., January 15, 2007; 81(2): 903 - 916.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y. Jin, C. Cao, P. Li, X. Liu, W. Huang, C. Li, and Q. Ma
Boosting Immune Response to Hepatitis B DNA Vaccine by Coadministration of Prothymosin {alpha}-Expressing Plasmid
Clin. Vaccine Immunol., December 1, 2005; 12(12): 1364 - 1369.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
L. E. Pomeranz, A. E. Reynolds, and C. J. Hengartner
Molecular Biology of Pseudorabies Virus: Impact on Neurovirology and Veterinary Medicine
Microbiol. Mol. Biol. Rev., September 1, 2005; 69(3): 462 - 500.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. Mwangi, W. C. Brown, G. A. Splitter, Y. Zhuang, K. Kegerreis, and G. H. Palmer
Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection
J. Leukoc. Biol., August 1, 2005; 78(2): 401 - 411.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L. Aurelian
Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?
Clin. Vaccine Immunol., May 1, 2004; 11(3): 437 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Nishimura, T. Yajima, Y. Kagimoto, M. Ohata, T. Watase, K. Kishihara, F. Goshima, Y. Nishiyama, and Y. Yoshikai
Intraepithelial {gamma}{delta} T Cells May Bridge a Gap between Innate Immunity and Acquired Immunity to Herpes Simplex Virus Type 2
J. Virol., May 1, 2004; 78(9): 4927 - 4930.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. van Lint, M. Ayers, A. G. Brooks, R. M. Coles, W. R. Heath, and F. R. Carbone
Herpes Simplex Virus-Specific CD8+ T Cells Can Clear Established Lytic Infections from Skin and Nerves and Can Partially Limit the Early Spread of Virus after Cutaneous Inoculation
J. Immunol., January 1, 2004; 172(1): 392 - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. N. Toka, M. Gierynska, and B. T. Rouse
Codelivery of CCR7 Ligands as Molecular Adjuvants Enhances the Protective Immune Response against Herpes Simplex Virus Type 1
J. Virol., December 1, 2003; 77(23): 12742 - 12752.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Fischer, O. Planz, L. Stitz, and H.-J. Rziha
Novel Recombinant Parapoxvirus Vectors Induce Protective Humoral and Cellular Immunity against Lethal Herpesvirus Challenge Infection in Mice
J. Virol., September 1, 2003; 77(17): 9312 - 9323.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
I. K. Srivastava and M. A. Liu
Gene Vaccines
Ann Intern Med, April 1, 2003; 138(7): 550 - 559.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Velikovsky, J. Cassataro, G. H. Giambartolomei, F. A. Goldbaum, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and M. Spitz
A DNA Vaccine Encoding Lumazine Synthase from Brucella abortus Induces Protective Immunity in BALB/c Mice
Infect. Immun., May 1, 2002; 70(5): 2507 - 2511.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. BAGHIAN, V. N. CHOULJENKO, O. D'AUVERGNE, M. J. NEWMAN, S. BAGHIAN, and K. G. KOUSOULAS
Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD
J. Med. Microbiol., April 1, 2002; 51(4): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. E. Pertel
Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion
J. Virol., March 27, 2002; 76(9): 4390 - 4400.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Brockman and D. M. Knipe
Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity
J. Virol., March 19, 2002; 76(8): 3678 - 3687.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse
IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis
J. Leukoc. Biol., March 1, 2002; 71(3): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. M. McNeal, J. L. VanCott, A. H. C. Choi, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, and R. L. Ward
CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G)
J. Virol., January 15, 2002; 76(2): 560 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
H. L. Glansbeek, B. L. Haagmans, E. G. te Lintelo, H. F. Egberink, V. Duquesne, A. Aubert, M. C. Horzinek, and P. J. M. Rottier
Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus
J. Gen. Virol., January 1, 2002; 83(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Eo, U. Kumaraguru, and B. T. Rouse
Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells
J. Immunol., October 1, 2001; 167(7): 3592 - 3599.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. R. Bosarge, J. M. Watt, D. O. McDaniel, E. Swiatlo, and L. S. McDaniel
Genetic Immunization with the Region Encoding the {alpha}-Helical Domain of PspA Elicits Protective Immunity against Streptococcus pneumoniae
Infect. Immun., September 1, 2001; 69(9): 5456 - 5463.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Deshpande, M. Zheng, S. Lee, K. Banerjee, S. Gangappa, U. Kumaraguru, and B. T. Rouse
Bystander Activation Involving T Lymphocytes in Herpetic Stromal Keratitis
J. Immunol., September 1, 2001; 167(5): 2902 - 2910.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
V. Kumar, J. Maglione, J. Thatte, B. Pederson, E. Sercarz, and E. S. Ward
Induction of a type 1 regulatory CD4 T cell response following V{beta}8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis
Int. Immunol., June 1, 2001; 13(6): 835 - 841.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Eo, M. Gierynska, A. A. Kamar, and B. T. Rouse
Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules
J. Immunol., May 1, 2001; 166(9): 5473 - 5479.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Nikiforow, K. Bottomly, and G. Miller
CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
J. Virol., April 15, 2001; 75(8): 3740 - 3752.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. P. Deshpande, S. Lee, M. Zheng, B. Song, D. Knipe, J. A. Kapp, and B. T. Rouse
Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis
J. Virol., April 1, 2001; 75(7): 3077 - 3088.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Jilek, C. Barbey, F. Spertini, and B. Corthesy
Antigen-Independent Suppression of the Allergic Immune Response to Bee Venom Phospholipase A2 by DNA Vaccination in CBA/J Mice
J. Immunol., March 1, 2001; 166(5): 3612 - 3621.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse
Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines
J. Virol., January 15, 2001; 75(2): 569 - 578.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu
Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model
J. Immunol., January 15, 2001; 166(2): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Kumaraguru, I. A. Davis, S. Deshpande, S. S. Tevethia, and B. T. Rouse
Lymphotoxin {{alpha}}-/- Mice Develop Functionally Impaired CD8+ T Cell Responses and Fail to Contain Virus Infection of the Central Nervous System
J. Immunol., January 15, 2001; 166(2): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Inoue, Y. Inoue, T. Nakamura, A. Yoshida, K. Takahashi, Y. Inoue, Y. Shimomura, Y. Tano, Y. Fujisawa, A. Aono, et al.
Preventive Effect of Local Plasmid DNA Vaccine Encoding gD or gD-IL-2 on Herpetic Keratitis
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4209 - 4215.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner
DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo
J. Virol., December 1, 2000; 74(23): 11173 - 11180.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
S.-A. Chen, M.-H. T. F.-T. Wu, A. Hsiang, Y.-L. Chen, H.-Y. Lei, T.-S. Tzai, H. W. C. Leung, Y.-T. Jin, C.-L. Hsieh, L.-H. Hwang, et al.
Induction of Antitumor Immunity with Combination of HER2/neu DNA Vaccine and Interleukin 2 Gene-modified Tumor Vaccine
Clin. Cancer Res., November 1, 2000; 6(11): 4381 - 4388.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Tsunobuchi, H. Nishimura, F. Goshima, T. Daikoku, Y. Nishiyama, and Y. Yoshikai
Memory-Type CD8+ T Cells Protect IL-2 Receptor {alpha}-Deficient Mice from Systemic Infection with Herpes Simplex Virus Type 2
J. Immunol., October 15, 2000; 165(8): 4552 - 4560.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J.-I. Sin, J. Kim, C. Patchuk, and D. B. Weiner
Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo
Clin. Vaccine Immunol., September 1, 2000; 7(5): 751 - 758.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Kumaraguru, R. J. D. Rouse, S. K. Nair, B. D. Bruce, and B. T. Rouse
Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization
J. Immunol., July 15, 2000; 165(2): 750 - 759.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. P. Deshpande, M. Zheng, M. Daheshia, and B. T. Rouse
Pathogenesis of Herpes Simplex Virus-Induced Ocular Immunoinflammatory Lesions in B-Cell-Deficient Mice
J. Virol., April 15, 2000; 74(8): 3517 - 3524.
[Abstract] [Full Text]


Home page
IOVSHome page
S. Gangappa, S. P. Deshpande, and B. T. Rouse
Bystander Activation of CD4+ T Cells Accounts for Herpetic Ocular Lesions
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 453 - 459.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
J.-I. Sin, V. Ayyavoo, J. Boyer, J. Kim, R. B. Ciccarelli, and D. B. Weiner
Protective immune correlates can segregate by vaccine type in a murine herpes model system
Int. Immunol., November 1, 1999; 11(11): 1763 - 1773.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Suter, A. M. Lew, P. Grob, G. J. Adema, M. Ackermann, K. Shortman, and C. Fraefel
BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1
PNAS, October 26, 1999; 96(22): 12697 - 12702.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. A. Belperron, D. Feltquate, B. A. Fox, T. Horii, and D. J. Bzik
Immune Responses Induced by Gene Gun or Intramuscular Injection of DNA Vaccines That Express Immunogenic Regions of the Serine Repeat Antigen from Plasmodium falciparum
Infect. Immun., October 1, 1999; 67(10): 5163 - 5169.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. C. Winkler, A. Doster, and C. Jones
Bovine Herpesvirus 1 Can Infect CD4+ T Lymphocytes and Induce Programmed Cell Death during Acute Infection of Cattle
J. Virol., October 1, 1999; 73(10): 8657 - 8668.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Chun, M. Daheshia, S. Lee, S. K. Eo, and B. T. Rouse
Distribution Fate and Mechanism of Immune Modulation Following Mucosal Delivery of Plasmid DNA Encoding IL-10
J. Immunol., September 1, 1999; 163(5): 2393 - 2402.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Watanabe, R. G. Fenton, J. M. Wigginton, K. L. McCormick, K. M. Volker, W. E. Fogler, P. G. Roessler, and R. H. Wiltrout
Intradermal Delivery of IL-12 Naked DNA Induces Systemic NK Cell Activation and Th1 Response In Vivo That Is Independent of Endogenous IL-12 Production
J. Immunol., August 15, 1999; 163(4): 1943 - 1950.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Noisakran, I. L. Campbell, and D. J. J. Carr
Ectopic Expression of DNA Encoding IFN-{alpha}1 in the Cornea Protects Mice from Herpes Simplex Virus Type 1-Induced Encephalitis
J. Immunol., April 1, 1999; 162(7): 4184 - 4190.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-I. Sin, J. J. Kim, R. L. Arnold, K. E. Shroff, D. McCallus, C. Pachuk, S. P. McElhiney, M. W. Wolf, S. J. Pompa-de Bruin, T. J. Higgins, et al.
IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge
J. Immunol., March 1, 1999; 162(5): 2912 - 2921.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-I. Sin, J. J. Kim, J. D. Boyer, R. B. Ciccarelli, T. J. Higgins, and D. B. Weiner
In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model
J. Virol., January 1, 1999; 73(1): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. E. Blaney Jr., E. Nobusawa, M. A. Brehm, R. H. Bonneau, L. M. Mylin, T.-M. Fu, Y. Kawaoka, and S. S. Tevethia
Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity
J. Virol., December 1, 1998; 72(12): 9567 - 9574.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Adam. D. Cohen, J. D. Boyer, and D. B. Weiner
Modulating the immune response to genetic immunization
FASEB J, December 1, 1998; 12(15): 1611 - 1626.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y. Kang, P. A. Calvo, T. M. Daly, and C. A. Long
Comparison of Humoral Immune Responses Elicited by DNA and Protein Vaccines Based on Merozoite Surface Protein-1 from Plasmodium yoelii, a Rodent Malaria Parasite
J. Immunol., October 15, 1998; 161(8): 4211 - 4219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gangappa, J. S. Babu, J. Thomas, M. Daheshia, and B. T. Rouse
Virus-Induced Immunoinflammatory Lesions in the Absence of Viral Antigen Recognition
J. Immunol., October 15, 1998; 161(8): 4289 - 4300.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Wang and G. A. Splitter
CD4+ Cytotoxic T-Lymphocyte Activity against Macrophages Pulsed with Bovine Herpesvirus 1 Polypeptides
J. Virol., September 1, 1998; 72(9): 7040 - 7047.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Chun, M. Daheshia, N. A. Kuklin, and B. T. Rouse
Modulation of Viral Immunoinflammatory Responses with Cytokine DNA Administered by Different Routes
J. Virol., July 1, 1998; 72(7): 5545 - 5551.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. B. Ulmer, T.-M. Fu, R. R. Deck, A. Friedman, L. Guan, C. DeWitt, X. Liu, S. Wang, M. A. Liu, J. J. Donnelly, et al.
Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA
J. Virol., July 1, 1998; 72(7): 5648 - 5653.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sjolander, T. M. Baldwin, J. M. Curtis, and E. Handman
Induction of a Th1 Immune Response and Simultaneous Lack of Activation of a Th2 Response Are Required for Generation of Immunity to Leishmaniasis
J. Immunol., April 15, 1998; 160(8): 3949 - 3957.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Thomas and B. T. Rouse
Immunopathology of Herpetic Stromal Keratitis: Discordance in CD4+ T Cell Function Between Euthymic Host and Reconstituted SCID Recipients
J. Immunol., April 15, 1998; 160(8): 3965 - 3970.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. Hariharan, D. A. Driver, K. Townsend, D. Brumm, J. M. Polo, B. A. Belli, D. J. Catton, D. Hsu, D. Mittelstaedt, J. E. McCormack, et al.
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
J. Virol., February 1, 1998; 72(2): 950 - 958.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Andre, B. Seed, J. Eberle, W. Schraut, A. Bultmann, and J. Haas
Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage
J. Virol., February 1, 1998; 72(2): 1497 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-H. Chow, B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Lin, Y.-T. Chen, and M.-H. Tao
Development of Th1 and Th2 Populations and the Nature of Immune Responses to Hepatitis B Virus DNA Vaccines Can Be Modulated by Codelivery of Various Cytokine Genes
J. Immunol., February 1, 1998; 160(3): 1320 - 1329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.